검색
검색 팝업 닫기

Best Practice

As an open access journal, Journal of the Korean Dysphagia Society(JKDS) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

  • 1. Website & General Information
    • i. The URL address of official journal web site is https://jkds.org/.
    • ii. 'Aims & Scope' statement: The journal welcomes articles on clinical practice and investigative research related to dysphagia.
        • Basic research
        • Clinical research
        • Epidemiologic studies
        • Research on health services
        • Medical system research
    • iii. Readership: Prospective readers include, but are not limited to: physician (Rehabilitation Medicine, Otorhinolaryngology-Head and Neck Surgery, Internal Medicine); occupational therapist and speech-language pathologist; nutritionist; nurses; social workers; other personnel involved in research or policy-making related to dysphagia.
    • iv. Authorship criteria: Authorship credit should be based on
      1. 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data;
      2. 2) drafting the article or revising it critically for important intellectual content;
      3. 3) final approval of the version to be published;
      4. 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
          - Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
          - If a researcher wishes to publish an article jointly with a related person such as a minor (a person under the age of 19) or a family member (within a fourth degree, such as a spouse, child, etc.), the researcher must obtain permission by notifying the editorial office of the type of related person and the reason for participation.
          - Corresponding author and first author: Journal of the Korean Dysphagia Society allows multiple corresponding authors and multiple first authors for one article. Authors should provide notice for equal contribution for the first author when the study was clearly performed by co-first authors.
          - Correction of authorship after publication: Journal of the Korean Dysphagia Society does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
    • v. Duplicate submission and redundant publication: Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by KCI (https://check.kci.go.kr/), a plagiarism-screening tool. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed. There will also be penalties for the authors. A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.
    • vi. pISSN: 2233-5978 eISSN; 2713-6191
  • 2. Name of Journal
    • The official journal title is the Journal of the Korean Dysphagia Society, the abbreviation of ISO is JKDS.
  • 3. Peer review process
    • The JKDS has on online submission and peer review system at https://jkds.org/.submission/Login.html

      Journal of the Korean Dysphagia Society reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these two criteria, it is dispatched to at least two investigators in the field with relevant knowledge. Assuming the manuscript is sent to reviewers, Journal of the Korean Dysphagia Society waits to receive opinions from at least two reviewers. In addition, if deemed necessary, a review of statistics may be requested. If the opinions of the two reviewers are different, the editorial office selects a third reviewer for additional peer review. The authors’ names and affiliations are removed during peer review. The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers.
      An initial decision will normally be made within 4 weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. The corresponding author must indicate the alterations that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. A final decision on acceptance/rejection for publication is forwarded to the corresponding author from the editor.

      All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the decision process. Editors will not handle their own manuscripts although they are commissioned ones. We neither guarantee the acceptance without review nor very short peer review times for unsolicited manuscripts. Commissioned manuscripts are also reviewed before publication. We adopt double-blind peer review for all manuscripts, in which not only authors but also reviewers do not know each other.

  • 4. Ownership and management
    • i. Information about the ownership: This journal is owned by the publisher, the Korean Dysphagia Society (KDS).
      (https://www.kdys.or.kr).
    • ii. Management team of the journal:
      This journal is managed by a team listed on the editorial board.
  • 5/6. Governing body / Editorial Team and Contact Information
    • The governing body is the journal's editorial board. The full names and affiliations of the journal’s editors and members of journal management team are displayed on the About (Editorial Board & Journal Management Team) tab of journal homepage, and the contact information for the Editor and editorial office is on the About (Contact Us) tab.
  • 7. Copyright and Licensing
    • i. Copyright policy: All published papers become the permanent property of the Korean Dysphagia Society. Copyrights of all published materials are owned by the Korean Dysphagia Society. Permission must be obtained from the Korean Dysphagia Society for any commercial use of materials. Every author should sign the copyright transfer agreement forms.
    • ii. This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose.
    • iii. Deposit policy: According to the deposit policy (self-archiving policy) of Sherpa/Romeo, authors cannot archive pre-print (i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.
  • 8. Author fees
    • JKDS uses the Open Access publishing model in which all published articles are freely available to readers directly from the Journal's website. This publishing model, however, is based on author fees. The submissions of a manuscript and peer-review process are free of charge. The processing fee applies only to manuscripts accepted for publication.
  • 9. Process for the identification of and dealing with allegations of research misconduct
    • The editorial board of JKDS have carefully examined all submitted manuscripts whether these are abided by the ethical guidelines of the ICMJE and COPE. The published articles have involved the statements of conflict of interest, institutional review board, informed consent, and human/animal rights.

      When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the COPE (https://publicationethics.org/resources/flowcharts). The editorial board of JKDS will discuss the suspected cases and reach a decision. JKDS will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

  • 10. Publication Ethics
    • i. Journal policies on authorship and contributorship
      Authorship credit should be based on
      1. 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data;
      2. 2) drafting the article or revising it critically for important intellectual content;
      3. 3) final approval of the version to be published; and
      4. 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
          - Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
          - Corresponding author and first author: Journal of the Korean Dysphagia Society allows multiple corresponding authors and multiple first authors for one article. Authors should provide notice for equal contribution for the first author when the study was clearly performed by co-first authors.
          - Correction of authorship after publication: Journal of the Korean Dysphagia Society does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
    • ii. How the journal will handle complaints and appeals:
      The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics.
      - Who complains or makes an appeal?
      Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform the cases, they can send a letter to the editor for the complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) should be provided.
      - Who is responsible to resolve and handle complaints and appeals?
      The Editor, Editorial Board, or Editorial Office is responsible for them.
      - What may be the consequence of remedy?
      It depends on the type or degree of misconduct. The consequence of resolution will follow the guidelines of the Committee of Publication Ethics (COPE).
    • iii. Journal policies on conflicts of interest / competing interests
      The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
    • iv. Journal policies on data sharing and reproducibility
      - Open data policy
      For clarification on result accuracy and reproducibility of the results, it is recommended that the raw or analytical data be deposited in a public repository such as Harvard Dataverse (https://dataverse.harvard.edu/dataverse/) after manuscript approval. If the data is already a public one, its URL site or sources should be disclosed. If data cannot be publicized, it can be negotiated with the editor. If there are any inquiries on depositing data, authors should contact the editorial office.

      - Clinical data sharing policy
      This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors”. As of July 1, 2018, manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan of example 1 to 4 in Table 1. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.

      Table 1. Examples of data sharing statements that fulfill ICMJE requirements*
      Element Example 1 Example 2 Example 3 Example 4
      Will individual participant data be available (including data dictionaries)? Yes Yes Yes No
      What data in particular will be shared? All individual participant data collected during the trial, after deidentification. Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Not available
      What other documents will be available? Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code Study protocol, statistical analysis plan, analytic code Study protocol Not available
      When will data be available (start and end dates)? Immediately following publication. No end date. Beginning at 3 months and ending at 5 years following the article publication. Beginning at 9 months and ending at 36 months following the article publication. Not available
      With whom? Anyone who wishes to access the data. Researchers who provide a methodologically sound proposal. Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose. Not available
      For what types of analyses? Any purpose To achieve aims in the approved proposal. For individual participant data meta-analysis. Not available
      By what mechanism will data be made available? Data are available indefinitely at (link to be included). Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Not available
      Data are available for 5 years at a third-party Information regarding submitting
      Website (link to be included). Proposals and accessing data may be found at (link to be provided).
      ICMJE = International Committee of Medical Journal Editors.
      *These examples are meant to illustrate a range of, but not all, data sharing options.
    • v. Research ethics
      All of the manuscripts should be prepared in strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), World Association of Medical Editors (WAME, http://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE, http://www.kamje.or.kr/intro.php?body=eng_index). Any study including human subjects or human data must be reviewed and approved by a responsible institutional review board (IRB). Please refer to the principles embodied in the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html) for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC). The editor of JKDS may request submission of copies of informed consents from human subjects in clinical studies or IRB approval documents. The JKDS will follow the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) for settlement of any misconduct.
    • vi. Conflict of interest
      The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing their interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may be financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems. Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf). The Editor will decide whether the information on the conflict should be included in the published paper. Before publishing such information, the Editor will consult with the corresponding author. In particular, all sources of funding for a study should be explicitly stated. The JKDS asks referees to let its Editor know of any conflict of interest before reviewing a particular manuscript.
    • vii. Journal's policy on ethical oversight
      When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the Committee on Publication Ethics. The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
    • viii. Journal's policy on intellectual property
      All published papers become the permanent property of the Korean Dysphagia Society. Copyrights of all published materials are owned by the Korean Dysphagia Society.
    • ix. Journal's options for post-publication discussions and corrections
      The post-publication discussion is available through letter to editor. If any readers have a concern on any articles published, they can submit letter to editor on the articles. If there founds any errors or mistakes in the article, it can be corrected through errata, corrigenda, or retraction.
  • 11. Publishing schedule
    • JKDS is published twice (the last day of January, July) a year.
  • 12. Access
    • JKDS is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.
  • 13. Archiving
    • It is accessible without barrier from KoreaMed, Korea Citation Index or National Library of Korea in the event a journal is no longer published.
  • 14. Revenue sources
    • Revenue sources of journal are from the support of publisher (Korean Dysphagia Society) and advertising rates.
  • 15. Advertising
    • JKDS accepts advertisements. The policy of advertising is displayed on the Editorial Policy (Advertising Policy) tab of journal homepage.
  • 16. Direct marketing
    • Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.
The Korean Journal of THORACIC AND CARDIOVASCULAR SUGERY

Current Issue

July, 2021
Vol.11 No.2

Most Read

Most Cited

  • There are no article in this list for that category yet.